Skip to main content
. 2022 May 21;127(4):766–775. doi: 10.1038/s41416-022-01842-2

Table 1.

Comparison of the performance (in terms of AUC) of published gene signatures (GS) identifying pCR when applied to our primary patient cohort (n = 161) and the one from Millino et al. [31] (n = 38).

Test set our signature GS1 GS2 GS3 GS4 GS5
161 samples 0.81 0.51 0.55 0.61 0.27 0.59
38 0.76 0.48 0.68 0.63 0.74 0.4

GS1 was published by Lopes-Ramos et al. [29]; GS2 by Ghadimi et al. [39]; GS3 by Empuko et al. [40]; GS4 by Watanabe et al. [38] and GS5 by Kim et al. [41].